EV/EBITDA
-0.43
+0.03+6.52%
72 min ago
Summary
- As of February 8, 2025, AVTE EV/EBITDA is -0.43, with a rise of +0.03 (+6.52%) during the most recent trading day.
- Over the past year, AVTE EV/EBITDA has increased by +6.32 (+93.63%).
- AVTE EV/EBITDA is now -152.94% below its all-time high of -0.17.
Performance
AVTE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AVTE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +6.5% | -7.0% | -4.0% |
| 1 m1 month | +12.2% | -13.3% | -8.1% |
| 3 m3 months | +18.9% | -18.9% | -11.8% |
| 6 m6 months | -126.3% | +115.8% | +42.5% |
| ytdytd | +17.3% | -18.6% | -11.5% |
| 1 y1 year | +93.6% | -93.0% | -88.4% |
| 5 y5 years | - | - | - |
AVTE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.51 | +15.7% | |
| 3 m | 3-month | -0.43 | at high | -0.58 | +25.9% |
| 6 m | 6-month | -0.18 | -138.9% | -0.58 | +25.9% |
| 1 y | 1-year | -0.17 | -152.9% | -9.85 | +95.6% |
| 3 y | 3-year | -0.17 | -152.9% | -16.70 | +97.4% |
| 5 y | 5-year | -0.17 | -152.9% | -33.89 | +98.7% |
| alltime | all time | -0.17 | -152.9% | -33.89 | +98.7% |
Aerovate Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.43(-17.3%) |
| 2024 | -0.52(-93.0%) |
| Date | Value |
|---|---|
| 2023 | -7.45(-43.6%) |
| 2022 | -13.22(+29.9%) |
| 2021 | -10.18 |
FAQ
- What is Aerovate Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aerovate Therapeutics?
- What is AVTE EV/EBITDA year-to-date change?
- What is Aerovate Therapeutics EV/EBITDA year-on-year change?
What is Aerovate Therapeutics EV/EBITDA?
The current EV/EBITDA of AVTE is -0.43
What is the all time high EV/EBITDA for Aerovate Therapeutics?
Aerovate Therapeutics all-time high EV/EBITDA is -0.17
What is AVTE EV/EBITDA year-to-date change?
Aerovate Therapeutics EV/EBITDA has changed by +0.09 (+17.31%) since the beginning of the year
What is Aerovate Therapeutics EV/EBITDA year-on-year change?
Over the past year, AVTE EV/EBITDA has changed by +6.32 (+93.63%)